MX9703339A - Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina. - Google Patents

Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.

Info

Publication number
MX9703339A
MX9703339A MX9703339A MX9703339A MX9703339A MX 9703339 A MX9703339 A MX 9703339A MX 9703339 A MX9703339 A MX 9703339A MX 9703339 A MX9703339 A MX 9703339A MX 9703339 A MX9703339 A MX 9703339A
Authority
MX
Mexico
Prior art keywords
storage stable
thrombin inhibitor
water solution
stable water
infusion containing
Prior art date
Application number
MX9703339A
Other languages
English (en)
Inventor
Ulla Stjernfelt
Mats Sundgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9703339A publication Critical patent/MX9703339A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invencion se relaciona con una solucion acuosa concentrada para infusion, estable al almacenamiento, que tiene un pH en el intervalo de 1.0 a 2.5 y que contiene un inhibidor activo de trombina que tiene la formula: HOOC-CH2- Y, en la que Y es (R)-Cha-Pic-Nag o (R)-Cgl-Aze-Pab, como una sal o como una base libre del mismo, con un proceso para su preparacion y con un método para tratamiento de un paciente en necesidad de tal formulacion.
MX9703339A 1994-11-08 1995-10-19 Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina. MX9703339A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403831A SE504185C2 (sv) 1994-11-08 1994-11-08 Lagringsstabil vattenlösning för infusion av trombininhibitorer
PCT/SE1995/001228 WO1996014084A1 (en) 1994-11-08 1995-10-19 A storage stable water solution for infusion containing a thrombin inhibitor

Publications (1)

Publication Number Publication Date
MX9703339A true MX9703339A (es) 1997-07-31

Family

ID=20395892

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703339A MX9703339A (es) 1994-11-08 1995-10-19 Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.

Country Status (31)

Country Link
US (1) US5830865A (es)
EP (1) EP0789585B1 (es)
JP (1) JPH10508598A (es)
KR (1) KR100416677B1 (es)
CN (1) CN1090508C (es)
AT (1) ATE205399T1 (es)
AU (1) AU695719B2 (es)
BR (1) BR9509634A (es)
CA (1) CA2203396A1 (es)
CZ (1) CZ287256B6 (es)
DE (1) DE69522702T2 (es)
DK (1) DK0789585T3 (es)
EE (1) EE9700218A (es)
ES (1) ES2163528T3 (es)
FI (1) FI971949A0 (es)
HU (1) HU217073B (es)
IL (1) IL115879A (es)
IS (1) IS4468A (es)
MX (1) MX9703339A (es)
MY (1) MY112593A (es)
NO (1) NO322048B1 (es)
NZ (1) NZ295492A (es)
PL (1) PL320342A1 (es)
PT (1) PT789585E (es)
RU (1) RU2164803C2 (es)
SE (1) SE504185C2 (es)
SK (1) SK53597A3 (es)
TR (1) TR199501391A2 (es)
TW (1) TW407057B (es)
WO (1) WO1996014084A1 (es)
ZA (1) ZA959377B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) * 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
TWI238827B (en) * 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9802974D0 (sv) * 1998-09-03 1998-09-03 Astra Ab New crystalline forms
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2011038068A1 (en) * 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5466131A (en) * 1994-03-22 1995-11-14 Micropump Corporation Multiple-chamber gear pump with hydraulically connected chambers

Also Published As

Publication number Publication date
FI971949A (fi) 1997-05-07
PL320342A1 (en) 1997-09-29
US5830865A (en) 1998-11-03
EP0789585A1 (en) 1997-08-20
HU217073B (hu) 1999-11-29
FI971949A0 (fi) 1997-05-07
ES2163528T3 (es) 2002-02-01
IL115879A (en) 2001-08-08
RU2164803C2 (ru) 2001-04-10
NO322048B1 (no) 2006-08-07
CN1090508C (zh) 2002-09-11
CN1162921A (zh) 1997-10-22
CA2203396A1 (en) 1996-05-17
TR199501391A2 (tr) 1996-06-21
HUT77560A (hu) 1998-06-29
NZ295492A (en) 1998-06-26
EP0789585B1 (en) 2001-09-12
DK0789585T3 (da) 2001-11-12
BR9509634A (pt) 1998-01-06
SK53597A3 (en) 1998-07-08
MY112593A (en) 2001-07-31
KR970706844A (ko) 1997-12-01
TW407057B (en) 2000-10-01
CZ129497A3 (cs) 1998-02-18
NO972065D0 (no) 1997-05-05
IS4468A (is) 1997-04-21
DE69522702T2 (de) 2002-07-11
ATE205399T1 (de) 2001-09-15
CZ287256B6 (en) 2000-10-11
NO972065L (no) 1997-05-05
PT789585E (pt) 2002-01-30
SE504185C2 (sv) 1996-12-02
EE9700218A (et) 1998-02-16
AU695719B2 (en) 1998-08-20
ZA959377B (en) 1996-05-08
SE9403831L (sv) 1996-05-09
WO1996014084A1 (en) 1996-05-17
KR100416677B1 (ko) 2004-06-16
IL115879A0 (en) 1996-01-31
SE9403831D0 (sv) 1994-11-08
AU3884695A (en) 1996-05-31
JPH10508598A (ja) 1998-08-25
DE69522702D1 (de) 2001-10-18

Similar Documents

Publication Publication Date Title
ES8702793A1 (es) Un procedimiento para desinfectar un substrato
EP0662117A1 (de) Schwachalkalische geschirreinigungsmittel
EP1281722A4 (en) HYALURONIC ACID GEL, METHOD FOR THE PRODUCTION THEREOF, AND THE MEDICAL MATERIAL CONTAINING GEL
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
CA2003190A1 (en) Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid
CA2132416A1 (en) Use of transglutaminase inhibitor for the treatment of scar tissue
MX9703339A (es) Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
AP2004003160A0 (en) Tolterodine salts
UA42837C2 (uk) Спосіб модулювання кальцієвих каналів у судинній та серцевій тканині
AU583970B2 (en) Guanidinobenzoic ester derivative
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
TH25616A (th) สารละลายในน้ำสำหรับฉีดที่มีความเสถียรในการเก็บซึ่งประกอบด้วยสารยับยั้งธรอมบิน
TH25616B (th) สารละลายในน้ำสำหรับฉีดที่มีความเสถียรในการเก็บซึ่งประกอบด้วยสารยับยั้งธรอมบิน
IL86136A0 (en) Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same
DE69630523D1 (de) Verwendung von Calciumkanalanantagonisten zur Behandlung von Herz-, Nieren-, Magen-und Darmkrankheiten sowie Bluthochdruck
RU97112901A (ru) Тромболитические средства
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE60105262D1 (de) ZUSAMMENSETZUNGEN enthaltend Monoperphthalatsäure ZUR BEHANDLUNG VON KONTAKTLINSEN
UA6882C2 (uk) Стерилізуючий засіб
ES2075798A1 (es) Derivados de aminoacidos naturales como inhibidores de metaloproteinasas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees